Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
legislation
Pharma
GSK-Hansoh, Merck-Kelun, AZ-Dizal—Fierce Pharma Asia
Kelun and Hansoh reported positive phase 3s for their Big Pharma-partnered ADCs. AZ buys an EGFR lung cancer med from its spinout Dizal. And more.
Angus Liu
Jul 17, 2026 9:38am
Bipartisan bill targets foreign drugmaking in US
Jul 16, 2026 11:27am
Germany approves controversial healthcare reform package
Jul 13, 2026 10:40am
How biosimilar developers are embracing next phase of US market
Jul 6, 2026 10:03am
Fierce Biotech
A divisive bill seeks to limit biotech investment in China
Jun 4, 2026 10:54am
White House touts $529B in MFN savings over 10 years
May 6, 2026 10:32am
